Skip to main content
Premium Trial:

Request an Annual Quote

Peter Wolstenholme, Klaus Sprockamp, Peter Willinger, Laura Robinson


Peter Wolstenholme has been appointed managing director of Stratagene Europe. Prior to joining Stratagene, Wolstenholme was vice president of sales and marketing at MWG Biotech. He received his bachelor of science degree from the University of Manchester in the UK, and has worked in management at Whatman, Biometra UK, and Orme Scientific.

Klaus Sprockamp, CFO of Lion Biosciences, has been reported missing since the World Trade Center attack September 11. Sprockamp was in a high floor of the World Trade Center South Tower, meeting with an investor, during the attack. Lion’s corporate controller, Peter Willinger, will perform CFO’s duties for now. Lion, based in Heidelberg, Germany, is the maker of ArrayScout and other bioinformatics software.

Laura Robinson, formerly product manager for Motorola Biochips, has been hired by Lion Biosciences to work out of the company’s San Diego office as product marketing manager for the iDea ADME prediction software tool.

This shift from microarrays to ADME software was a natural one, Robinson said, because both products are drug discovery tools. Robinson''s exit from Motorola follows the company''s consolidation of its Clinical Microsensors unit in Pasadena, Calif., with its Biochips division in Northbrook, Ill., into Motorola Life Sciences.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.